Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2013, Article ID 108401, 6 pages
http://dx.doi.org/10.1155/2013/108401
Research Article

Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis

1Korean Institute of Tuberculosis, 168-5, Osong sangmyung 4 ro, Osong-eup, Cheongwon-gun, Chungbuk 363-954, Republic of Korea
2Novartis Korea LTD, CD&MA, Namdaemunro 5-ga, Joon-gu 100-753, Republic of Korea
3Centers for Infectious Diseases, National Institute of Health, Korea Centers for Disease Control and Prevention, 187 Osong sangmyung 2 ro, Osong-eup, Cheongwon-gun, Chungbuk 363-951, Republic of Korea

Received 24 December 2012; Revised 7 March 2013; Accepted 11 March 2013

Academic Editor: Alexander S. Apt

Copyright © 2013 Hyejin Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hyejin Kim, Minji Seo, Young Kil Park, et al., “Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis,” Tuberculosis Research and Treatment, vol. 2013, Article ID 108401, 6 pages, 2013. https://doi.org/10.1155/2013/108401.